Public Health

Latest California Healthline Stories

KHN’s ‘What the Health?’: FDA Takes Center Stage

Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.

Missouri’s War on Public Health Shows Extent of National Rift

A public health official who said he was anti-abortion and anti-mandate for masks and covid vaccines did not pass the purity test of a Missouri senator who opposes covid public health restrictions. The senator killed the official’s nomination to be state health director, highlighting how hands may be tied in the nationwide fight against infectious diseases.